MetaADEDB 2.0 @ LMMD
17-alpha-Hydroxyprogesterone
(DBPWSSGDRRHUNT-CEGNMAFCSA-N)
Structure
SMILES
O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(O)C(=O)C)C)C
Type(s)
Experimental
ATC code(s)
G03DA03; G03FA02
Molecular Formula:
C21H30O3
Molecular Weight:
330.461
Log P:
3.8384
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
54.37
CAS Number(s):
68-96-2; 604-09-1
Synonym(s)
1.
17-alpha-Hydroxyprogesterone
2.
17-Hydroxyprogesterone
3.
17 alpha-Hydroxyprogesterone
4.
17-Hydroxyprogesterone, (17 alpha)-Isomer
5.
17-Hydroxyprogesterone, (9 beta, 10 alpha)-Isomer
6.
17 Hydroxyprogesterone
7.
17 alpha Hydroxyprogesterone
External Link(s)
MeSHD019326
PubChem Compound6238
BindingDB50423511
ChEBI17252
CHEMBLCHEMBL1062
DrugBankDB14570
IUPHAR/BPS Guide to PHARMACOLOGY5104
KEGGcpd:C01176
dr:D08052
Therapeutic Target DatabaseD06WBH
ZINC5434436
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Injection site painFAERS: 7SIDER
US FAERS
2Injection site erythemaFAERS: 5US FAERS
3Injection site pruritusFAERS: 5SIDER
US FAERS
4PruritusFAERS: 5SIDER
US FAERS
5Injection site massFAERS: 4US FAERS
6PainFAERS: 3US FAERS
7Gestational DiabetesFAERS: 2SIDER
US FAERS
8Maternal exposure during pregnancyFAERS: 2US FAERS
9Product dispensing errorFAERS: 2US FAERS
10Product substitution issueFAERS: 2US FAERS
11Back PainFAERS: 1US FAERS
12Burning sensationFAERS: 1US FAERS
13Drug dispensing errorFAERS: 1US FAERS
14ErythemaFAERS: 1SIDER
US FAERS
15FlushingFAERS: 1SIDER
US FAERS
16HypersensitivityFAERS: 1SIDER
US FAERS
17HypotensionFAERS: 1US FAERS
18Incorrect product storageFAERS: 1US FAERS
19Injection site bruisingFAERS: 1US FAERS
20Needle issueFAERS: 1US FAERS
21Post procedural complicationFAERS: 1US FAERS
22PregnancyFAERS: 1SIDER
US FAERS
23Procedural complicationFAERS: 1US FAERS
24Product prescribing issueFAERS: 1US FAERS
25Product storage errorFAERS: 1US FAERS
26Product use issueFAERS: 1US FAERS
27Reaction to preservativesFAERS: 1US FAERS
28ThrombosisFAERS: 1US FAERS
29UrticariaFAERS: 1SIDER
US FAERS
30Wrong drug administeredFAERS: 1US FAERS
31Wrong technique in product usage processFAERS: 1US FAERS
32AstheniaSIDER
33Chest PainSIDER
34Chest discomfortSIDER
35DermatitisSIDER
36DizzinessSIDER
37FatigueSIDER
38HeadacheSIDER
39InfectionSIDER
40Injection Site ReactionSIDER
41Injection site cellulitisSIDER
42Injection site noduleSIDER
43NauseaSIDER
44OligohydramniosSIDER
45Pre-EclampsiaSIDER
46Pulmonary EmbolismSIDER
47Shortened cervixSIDER
48StillbirthSIDER
49SwellingSIDER
50Urinary tract infectionSIDER
51VomitingSIDER
52nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.